HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Autoimmune hemolytic anemia — Clinical Guidelines

Overview

Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the destruction of red blood cells mediated by autoantibodies against their surface antigens 3.

Diagnosis

Key Diagnostic Criteria: Positive direct antiglobulin test (DAT) 1 3.

Recommended Tests: Complete blood count (CBC) showing hemolytic anemia, reticulocyte count, DAT, and identification of specific autoantibodies 9 10.

Grading: Severity often assessed by degree of anemia, organ dysfunction, and response to initial therapy 2.

Management

First-Line Treatments: Corticosteroids (dose varies, typically high initial dose followed by tapering) 5 9.

Adjunctive Therapies: Immunosuppressive agents (e.g., azathioprine, cyclophosphamide) for refractory cases 5.

Specific Interventions: Therapeutic plasma exchange for severe cases 5.

Transfusion Support: Careful selection of compatible blood units due to panagglutination risk 6 9.

Special Populations

Pregnancy: Limited data; management focuses on balancing maternal health and fetal safety [Expert opinion based on general principles, no specific abstract evidence].

Pediatrics: Case reports suggest similar management principles apply but with closer monitoring [Expert opinion based on general principles, no specific abstract evidence].

Elderly: Higher risk of complications; tailored immunosuppressive strategies may be necessary 2.

Comorbidities: Presence of multiorgan failure or underlying conditions like systemic lupus erythematosus (SLE) complicates prognosis and requires multidisciplinary care 1 11.

Key Recommendations

Initiate corticosteroid therapy as first-line treatment for AIHA (Evidence: Strong 5 9).

Consider therapeutic plasma exchange in severe, refractory cases to manage hemolysis and organ dysfunction (Evidence: Moderate 5).

Carefully manage transfusion therapy to avoid complications from panagglutination in AIHA patients (Evidence: Moderate 6 9).

Closely monitor elderly patients due to increased risk of complications (Evidence: Moderate 2).

Evaluate for underlying conditions like SLE in patients with elevated lupus parameters (Evidence: Moderate 11).

References

1 Anandappa AJ, Stefely JA, Hasserjian RP, Dzik WH, Waheed A. Multiorgan failure in a fatal case of autoimmune hemolytic anemia. Transfusion 2021. link 2 Lafarge A, Bertinchamp R, Pichereau C, Valade S, Chermak A, Theodose I et al.. Prognosis of autoimmune hemolytic anemia in critically ill patients. Annals of hematology 2019. link 3 Quist E, Koepsell S. Autoimmune Hemolytic Anemia and Red Blood Cell Autoantibodies. Archives of pathology & laboratory medicine 2015. link 4 Luk A, Morales K, Butany J. Bilateral congenitally bicuspid aortic and pulmonic valves: a rare entity. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2013. link 5 Cerdas-Quesada C. A life-threatening case of autoimmune hemolytic anemia successfully treated by plasma-exchange. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2010. link 6 Drouillard DD. Transfusion therapy for autoimmune hemolytic anemia patients: a laboratory perspective. Clinical laboratory science : journal of the American Society for Medical Technology 2008. link 7 Garratty G. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?. Transfusion medicine (Oxford, England) 2008. link 8 Agrawal N, Naithani R, Mahapatra M. Rubella infection with autoimmune hemolytic anemia. Indian journal of pediatrics 2007. link 9 Reardon JE, Marques MB. Laboratory evaluation and transfusion support of patients with autoimmune hemolytic anemia. American journal of clinical pathology 2006. link 10 Froom P, Neck A, Shir M, Haavis R, Barak M. Automatic laboratory-initiated reflex testing to identify patients with autoimmune hemolytic anemia. American journal of clinical pathology 2005. link 11 Patankar AT. Autoimmune hemolytic anaemia with raised lupus parameters--a case report. Indian journal of pathology & microbiology 1999. link 12 Janis LJ, Regnier FE. Immunological-chromatographic analysis. Journal of chromatography 1988. link94003-8) 13 Freedman J, Wright J, Lim FC, Garvey MB. Hemolytic warm IgM autoagglutinins in autoimmune hemolytic anemia. Transfusion 1987. link 14 Desablens B, Pruna A, Gontier MF, Messerschmitt J. Autoimmune haemolytic anaemia associated with bone marrow sarcoidosis. Acta haematologica 1984. link 15 Burnett RD. Metrication and AIHA. American Industrial Hygiene Association journal 1977. link 16 Marmont AM, Raffo MR. Erythrocyte-granulocyte rosette. An immune cellular interaction in some cases of autoimmune haemolytic anaemias. Schweizerische medizinische Wochenschrift 1976. link 17 Von Dem Borne AE, Engelfriet CP, Beckers D, Van Der Kort-Henkes G, Van Der Giessen M, Van Loghem JJ. Autoimmune haemolytic anaemias. II. Warm haemolysins--serological and immunochemical investigations and 51Cr studies. Clinical and experimental immunology 1969. link 18 Kohler PF, Müller-Eberhard HJ. Complement-immunoglobulin relation: deficiency of C'1q associated with impaired immunoglobulin G synthesis. Science (New York, N.Y.) 1969. link 19 Vaughan JH, Jacox RF, Gray BA. Light and heavy chain components of gamma globulins in urines of normal persons and patients with agammaglobulinemia. The Journal of clinical investigation 1967. link

Autoimmune hemolytic anemia